Canopy Growth Corp (CGC)
3.745
-0.20
(-4.95%)
USD |
NASDAQ |
Nov 14, 16:00
3.76
+0.02
(+0.40%)
After-Hours: 17:42
Canopy Growth Enterprise Value: 653.91M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 653.91M |
| November 12, 2024 | 653.91M |
| November 11, 2024 | 664.45M |
| November 08, 2024 | 685.52M |
| November 07, 2024 | 718.18M |
| November 06, 2024 | 652.73M |
| November 05, 2024 | 763.49M |
| November 04, 2024 | 754.11M |
| November 01, 2024 | 694.97M |
| October 31, 2024 | 669.63M |
| October 30, 2024 | 703.42M |
| October 29, 2024 | 731.58M |
| October 28, 2024 | 745.66M |
| October 25, 2024 | 749.41M |
| October 24, 2024 | 699.67M |
| October 23, 2024 | 711.87M |
| October 22, 2024 | 706.24M |
| October 21, 2024 | 646.16M |
| October 18, 2024 | 655.55M |
| October 17, 2024 | 643.35M |
| October 16, 2024 | 638.65M |
| October 15, 2024 | 626.45M |
| October 14, 2024 | 632.08M |
| October 11, 2024 | 618.00M |
| October 10, 2024 | 612.37M |
| Date | Value |
|---|---|
| October 09, 2024 | 617.07M |
| October 08, 2024 | 622.70M |
| October 07, 2024 | 633.02M |
| October 04, 2024 | 653.67M |
| October 03, 2024 | 668.69M |
| October 02, 2024 | 653.67M |
| October 01, 2024 | 652.73M |
| September 30, 2024 | 691.22M |
| September 27, 2024 | 655.02M |
| September 26, 2024 | 650.78M |
| September 25, 2024 | 641.44M |
| September 24, 2024 | 657.57M |
| September 23, 2024 | 655.02M |
| September 20, 2024 | 660.96M |
| September 19, 2024 | 666.90M |
| September 18, 2024 | 671.99M |
| September 17, 2024 | 682.18M |
| September 16, 2024 | 683.87M |
| September 13, 2024 | 673.69M |
| September 12, 2024 | 667.75M |
| September 11, 2024 | 666.90M |
| September 10, 2024 | 674.54M |
| September 09, 2024 | 678.78M |
| September 06, 2024 | 647.38M |
| September 05, 2024 | 669.45M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
573.53M
Minimum
Mar 14 2024
19.17B
Maximum
Feb 10 2021
3.741B
Average
2.279B
Median
May 10 2022
Enterprise Value Benchmarks
| Tilray Brands Inc | 1.353B |
| Aurinia Pharmaceuticals Inc | 836.78M |
| Edesa Biotech Inc | 5.103M |
| Lexaria Bioscience Corp | 26.69M |
| Xenon Pharmaceuticals Inc | 2.455B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -94.01M |
| Revenue (Quarterly) | 46.16M |
| Total Expenses (Quarterly) | 61.68M |
| EPS Diluted (Quarterly) | -1.084 |
| Gross Profit Margin (Quarterly) | 34.67% |
| Profit Margin (Quarterly) | -203.7% |
| Earnings Yield | -125.6% |
| Normalized Earnings Yield | -71.67 |